Validation & Transparency

Validated. Transparent. Trustworthy.

Every Zetyra calculator passes 51 automated validation tests against industry gold standards. Our Group Sequential Design module matches gsDesign R package within 0.005 z-score units—10× more accurate than typical commercial software tolerances.

At a Glance

51 automated tests passing
Max deviation: 0.0046 z-score
Benchmarked against gsDesign, pwr
HPTN 083 & HeartMate II replicated
Open source (MIT license)
Continuous integration

Open Source

Unlike proprietary alternatives, our validation is public.

Our complete validation suite runs continuously on GitHub Actions. Anyone can verify our accuracy, examine our methodology, and reproduce our results. No black boxes—just glass boxes.

View Live Validation Suite

Results Summary

Table 1

Validation Results by Calculator

CalculatorTestsReferenceMax DeviationStatus
Group Sequential Design30gsDesign R package0.0046 z-scorePass
CUPED12Analytical formulas< 0.001Pass
Bayesian9Conjugate priors< 0.01Pass

Real-World Validation

HPTN 083

Phase 3 HIV Prevention Trial

Design4-look O'Brien-Fleming
Boundaries tested4
Max deviation0.0046 z-score

HeartMate II

LVAD Clinical Trial

Design3-look O'Brien-Fleming
Info fractions[0.27, 0.67, 1.00]
StatusAll properties verified

Boundary Accuracy

23 boundary comparisons across 7 design configurations, all within 0.05 z-score tolerance.

Table 2

GSD Boundary Accuracy by Design

DesignLooksMax DeviationStatus
O'Brien-Fleming20.0000Pass
O'Brien-Fleming30.0001Pass
O'Brien-Fleming40.0017Pass
O'Brien-Fleming50.0046Pass
Pocock20.0000Pass
Pocock30.0002Pass
Pocock40.0008Pass

Methodology

gsDesign

Group Sequential Design

Validated against the gold-standard gsDesign R package. O'Brien-Fleming and Pocock spending functions computed to match FDA submission standards.

VRF = 1 - r²

CUPED

Variance reduction validated against analytical formulas. Sample size reduction proportional to baseline-outcome correlation squared.

Beta(a+x, b+n-x)

Bayesian

Conjugate posteriors validated analytically. Beta-Binomial and Normal-Normal models with exact predictive probability calculations.

References

  1. 1. GSD: Jennison & Turnbull (2000) Group Sequential Methods with Applications to Clinical Trials
  2. 2. CUPED: Deng et al. (2013) Improving the Sensitivity of Online Controlled Experiments (WSDM)
  3. 3. Bayesian: Gelman et al. (2013) Bayesian Data Analysis
  4. 4. gsDesign: Anderson (2022) gsDesign R package

The only clinical trial design platform with public, continuously validated accuracy.

Try our validated calculators today.